hollisterwoundcare
News & Events
News & Events
News
Events
News
April 15, 2010: Discovery Health Segment Features Advanced Technology from Hollister Wound Care
Approximately 18 million Americans suffer from diabetes. If left unmanaged and untreated, diabetes can be devastating, producing vision loss, decreased kidney function and severe, hard-to-heal wounds that can lead to amputation.1

The presence of chronic wounds can have a significant impact on a patient’s and family’s quality of life, in terms of pain and the ever-present risk of infection and further complications.  The elevated blood glucose levels in diabetic patients can cause wounds to heal more slowly. According to Dr. Gerit Mulder, Director of the Wound Treatment and Research Center at the University of California- San Diego, worldwide there is an amputation of a diabetic foot every 30 seconds2.

A Health Heroes segment on the Discovery Health network focusing on chronic wound care and featuring Hollister Wound Care’s Restore® products featuring TRIACT Technology™, originally scheduled to air during the week of April 12, 2010, will now be seen in 20 markets nationwide on Friday, April 30, 2010, at 7:00 a.m.

The segment includes interviews with diabetic patients, health care professionals and representatives of Hollister Wound Care, a leader in wound care technology, products and education.  The segment will also be available for viewing on the Discovery Health Web site, http://health.discovery.com/.

TRIACT Technology is a scientific, patented formulation used in Restore-brand wound care dressings.  TRIACT Technology’s unique lipido-colloid formulation helps create an exceptional wound-healing environment.  Additionally, TRIACT Technology is designed not to adhere to wounds, resulting in virtually pain free dressing changes.

According to Dr. Mary Regan, Director of Clinical Affairs for Hollister Wound Care, “In a study of 5,850 patients with both acute and chronic wounds, approximately 80 percent of participants reported ‘moderate to severe’ wound pain during the dressing change. Dressing removal was the most painful when there was adherence to the wound bed. When the same patients used the Restore dressings with TRIACT Technology, 95 percent of those with acute wounds and 88 percent of those with chronic wounds said their dressing changes were ‘less painful or not at all painful’3.”

The continued growth of the elderly population, coupled with the continuing increase in diabetes and other chronic illnesses, will require constant innovation in wound care technology that improves patients’ quality of life.

“Hollister Wound Care has an unwavering commitment to bring innovative solutions to the complex problems associated with wound care,” states Chip Ross, General Manager of Hollister Wound Care.  He adds, “Our ultimate goal is to help health care providers improve the quality of life for patients with chronic wounds.”  

1
National Diabetes Information Clearinghouse
2
International Diabetes Federation
3 Meaume S, Teot L, Lazareth I, Martini J, Bohbot S. The importance of pain reduction through dressing selection in routine wound management: the MAPP study. J Wound Care 2004;13;409-413.
April 2010: Hollister Wound Care Introduces the Latest Advancement in Foam Dressing Technology
Hollister Wound Care announces the launch of the new Restore® Foam Dressings featuring TRIACT ADVANCED™ Technology.

TRIACT ADVANCED Technology represents the newest advancement in foam dressings, and the latest innovation from Hollister Wound Care.

“We are excited to be launching these new innovative foams”, states Chip Ross, general manager of Hollister Wound Care.  “These products were specifically designed by partnering with clinicians to develop a solution that will meet both their clinical needs and help eliminate the pain the patient experiences during dressing changes.”

TRIACT ADVANCED Technology is a lipido-colloid formulation that is incorporated onto the surface of the dressing. The TRIACT ADVANCED interface differs from current silicone-based dressings in that it contains hydrocolloid (CMC) particles which gels in the presence of exudate and provide a moist healing interface between the wound and the dressing. In this way, the protective gel not only allows virtually pain-free removal of the dressing, but also maintains a moist wound interface for the duration of the indicated wear time.

“I have used several different foam dressings, and the Restore foam dressings with the TRIACT ADVANCED interface are a significant advancement for me and my patients,” states Dr. Patris Toney, DPM, MPH of the Sinai Institute for Lower Extremity Amputation Prevention in Chicago, IL. “The dressings absorb well and vertically wick away exudate, plus have a high moisture vapor transmission rate that many other foam dressings do not, which is important for maintaining healthy periwound tissue.  Patient acceptance has been very high because it is comfortable and conformable, and doesn’t hurt them or the wound tissue when it is removed.” 

The features of the new Restore foam dressings provide several key benefits:

· The TRIACT ADVANCED properties at the wound interface help prevent the dressing from sticking to the wound, while providing gentle micro-adherence to the periwound skin for one-handed application

· Upon contact with exudate, a protective gel forms allowing for virtually pain-free dressing changes

· A super-absorbent foam pad provides vertical wicking and containment of exudate, protecting the periwound skin from maceration

· A semi-permeable backing has high moisture vapor transmission rate which helps reduce maceration and preserve wound margins

Restore Foam Dressings with TRIACT ADVANCED Technology are available with and without border.  They are also available in LITE foam without border, which have the same features as the full-thickness foam dressings but with a thinner foam layer. 

For more information about the new Restore Foam Dressings and TRIACT ADVANCED Technology, contact your local Hollister sales representative or visit the company online at www.hollisterwoundcare.com.
Hollister Wound Care announces this year's "EB Healing Award" recipient
Hollister Wound Care was the Title Sponsor of the DebRA 11th Anniversary Mats Wilander Celebrity Tennis / Golf Classic on October 19, 2009.  In addition to being the Title Sponsor of this important DebRA Charity event, Hollister Wound Care also announced this year's recipient of the "HWC EB Healing Award"  This award was created in 2008 to assist families needing financial help in caring for an EB patient, and will be awarded annually.

The recipient of the 2009 Hollister EB Healing Award is a family of 5 from Pennsylvania.   The father and two of the children have EB.  The family has incurred many expenses from the father not being able to work and the mother working only part time.  Receiving this award and attending the DebRA event helped this family not only financially but has given them emotional support and confidence that they are not alone in dealing with this condition.
Hollister Wound Care awarded Novation contract!
Hollister Wound Care LLC has been awarded a Novation contract under the Novation New Technology Program--effective February 1, 2008. The award includes Hollister Wound Care's innovative products featuring TRIACT Technology that are targeted at reducing pain and bioburden.

TRIACT technology products have been designed to form an ideal wound environment and feature a scientific, patented formulation comprised of three key components:
  • 100% Non-Occlusive Mesh
  • Hydrocolloid particles
  • Petrolatum-Based Formulation

TRIACT technology allows for virtually pain-free dressing removal and can help reduce trauma to the wound and the patient.

Learn more about TRIACT Technology
Hollister Woundcare awarded full-line GPO contracts with Premier and MedAssets effective May 1, 2008
Hollister Wound Care LLC has been awarded 2 new GPO contracts with Premier and MedAssets--effective May 1, 2008. These awards are for the full line of Hollister Wound Care products, including the innovative TRIACT Technology products that are targeted at reducing pain and bioburden.
This page and its content is intended for U.S. customers only.